BioSpace News Archive

Pharm Country

Axovant to Host First R&D Day on March 29

Axovant’s chief executive officer, Pavan Cheruvu, MD, will provide opening remarks and Gavin Corcoran, MD, executive vice president of R&D, will moderate the event.

March 27, 2019
·
2 min read
Bio NC

Science Translational Medicine Publishes Results That Humacyte’s “Human Acellular Vessels Recellularize and Evolve into Living Blood Vessels following Human Implantation”

Humacyte, an innovator in biotechnology and regenerative medicine, announced publication in the medical journal Science Translational Medicine, of pivotal scientific work demonstrating Humacyte’s human acellular vessels (HAVs) repopulate with the patient’s own cells to form a living vascular tissue.

March 27, 2019
·
5 min read
Business

Ambry Genetics to Develop Custom Assays Targeted to Patients with Hereditary Ovarian Cancer

Investigating new testing options to identify patients for clinical trials.

March 27, 2019
·
1 min read
BioMidwest

Cook® Regentec Launches ProFusion™ Therapeutic Infusion Needle for Intramuscular or Subdermal Infusion of Therapeutic Agents

The device is now available in the United States and Canada.

March 27, 2019
·
1 min read
BioMidwest

Medline Announces Expanded Grant Program to Support Underserved Patients & Communities

Medline today announced a major expansion of its grant program to support community health centers across the United State

March 27, 2019
·
2 min read
Pharm Country

Watson-Marlow Fluid Technology Group to Demonstrate Quantum Peristaltic Pump at INTERPHEX 2019

Watson -Marlow Fluid Technology Group (WMFTG), fluid-in-motion expert, will be showcasing its unparalleled bioprocessing products at International Pharmaceutical (INTERPHEX) 2019, to be held April 2-4, 2019 at the Javits Center, in New York, NY.

March 27, 2019
·
1 min read
Pharm Country

Prevail Therapeutics Secures $50 Million in Series B Financing to Advance Pipeline of Gene Therapies for Neurodegenerative Diseases

Prevail Therapeutics Inc. (Prevail), a gene therapy company developing AAV-based gene therapies for patients with devastating neurodegenerative diseases, today announced it has raised $50 million in Series B financing

March 27, 2019
·
1 min read
Business

Phio Pharmaceuticals Reports Fourth Quarter and Year End 2018 Financial Results and Corporate Highlights

Phio Pharmaceuticals Corp. reported its financial results for the fourth quarter and year ended December 31, 2018 and provided a business update.

March 27, 2019
·
10 min read
Policy

Bayer Statement on Jury’s Decision in Phase 2 of California Glyphosate Trial

Bayer released the following statement in reaction to the phase two verdict in favor of the plaintiff in the case of Hardeman v Monsanto, a trial conducted in the federal glyphosate multi-district litigation before Judge Vince Chhabria in the Northern District of California.

March 27, 2019
·
3 min read
Biotech Bay

Covia Selects ADP Vantage for HR Solutions

After reviewing 11 potential service providers, Covia has chosen to partner with ADP for its human resources management system.

March 27, 2019
·
2 min read